NASDAQ:AVTX | Profit Margins | Avalo Therapeutics, Inc.

Complete source-backed margin history.

Available history
2016-09-30 to 2025-12-31
Data captured

Historical Profit Margins

DateGross marginOperating marginNet margin
2025-12-31—-33461.02%-23254.24%
2024-12-31—-6932.81%-18405.73%
2024-09-30—-5165.06%9251.81%
2023-12-31—-1341.16%-1430.47%
2023-09-30—-1588.98%-2215.25%
2023-06-30—-1111.98%-1274.18%
2023-03-31—-1850.95%-2095.79%
2022-12-31—-988.28%-1095.09%
2022-09-30—27.39%21.35%
2022-06-30—-1145.01%-1257.21%
2022-03-31—-1777.75%-1879.88%
2021-12-31—-8202.28%-8765.30%
2021-09-30—-1219.48%-1288.52%
2021-06-30—-510.55%-509.84%
2021-03-31—-6465.12%-6486.26%
2020-12-31—-1091.45%-1044.96%
2020-09-30—-1195.05%-1211.43%
2020-06-30—-883.03%-992.60%
2020-03-31—-1140.63%-766.78%
2019-12-31—-985.32%279.10%
2019-09-30—-130.00%-182.46%
2019-06-30—-183.06%-447.08%
2019-03-31—-194.26%-289.32%
2018-12-31—24.67%88.04%
2018-09-30—-596.68%-603.80%
2018-06-30—-120.22%-125.54%
2018-03-31—-83.75%-86.62%
2017-12-31—-195.07%-138.42%
2017-09-30—87.55%74.77%
2017-06-30—-1124.84%-1139.74%
2017-03-31—-494564.84%-510582.81%
2016-12-31—-931.67%-905.35%
2016-09-30—-1854.85%-1918.75%

Annual Profit Margins

DateGross marginOperating marginNet margin
2025-12-31—-123601.69%-132642.37%
2024-12-31—-15535.60%-7965.76%
2023-12-31—-1421.57%-1639.50%
2022-12-31—-207.41%-230.78%
2021-12-31—-1521.56%-1563.10%
2020-12-31—-1087.37%-947.90%
2019-12-31—-239.06%-238.10%
2018-12-31—-503.37%-569.87%
2017-12-31—49.94%42.68%
2016-12-31—-1394.64%-1428.60%